Results 1 to 10 of about 15,738 (196)
Esomeprazole inhibits proliferation of scleroderma fibroblasts via cell cycle regulation [PDF]
Frontiers in PharmacologyBackgroundScleroderma is a complex autoimmune disease characterized by abnormal fibroblast proliferation and excessive collagen deposits in the skin and internal organs.
Mohammad A. Khan +13 more
doaj +2 more sources
Esomeprazole and aspirin fixed combination for the prevention of cardiovascular events [PDF]
Vascular Health and Risk Management, 2013 Katelyn W Sylvester,1 Judy WM Cheng,1,3 Mandeep R Mehra2,41Department of Pharmacy, 2Department of Medicine, Brigham and Women’s Hospital, Boston, MA, USA; 3Massachusetts College of Pharmacy and Health Sciences, Boston, MA, 4Harvard Medical School ...
Sylvester KW, Cheng JW, Mehra MR
doaj +3 more sources
Effect of esomeprazole on lipid profile in patients with peptic ulcer [PDF]
Pharmacia, 2021 Esomeprazole; a newly introduced PPI has been widely prescribed by healthcare providers due to its improved pharmacokinetic profile. Most users could have other diseases and the PPIs are indicated as acid-suppressor to minimize gastric side effects of ...
Eman Abdullah +3 more
doaj +3 more sources
The pharmacokinetics and pharmacodynamics of esomeprazole in sheep after intravenous dosing
Frontiers in Veterinary Science, 2023 Abomasal (gastric) ulceration is a morbidity in sheep, and currently, there is a paucity of pharmacokinetic and pharmacodynamic data for gastroprotectant drugs reported for this species.
Joe S. Smith +11 more
doaj +1 more source
Pharmacokinetics of Esomeprazole in Critically Ill Patients
Frontiers in Medicine, 2022 BackgroundEsomeprazole, a potent proton pump inhibitor (PPI), is widely used for the prevention of stress ulcers in intensive care unit (ICU) patients.ObjectiveThis study investigates the pharmacokinetics (PK) of esomeprazole in critically ill patients ...
Yanyan Xu +7 more
doaj +1 more source
Oral Drug Absorption and Drug Disposition in Critically Ill Cardiac Patients
Pharmaceutics, 2023 (1) Background: In critically ill cardiac patients, parenteral and enteral food and drug administration routes may be used. However, it is not well known how drug absorption and metabolism are altered in this group of adult patients.
Lars-Olav Harnisch +10 more
doaj +1 more source
Bismuth-based quadruple therapy following H. Pylori eradication failures: A multicenter study in clinical practice [PDF]
, 2017 Background & Aims: Helicobacter pylori (H. pylori) eradication in patients who failed one or more therapeutic attempts remains challenging. This study aimed to assess the efficacy of three-in-one capsules bismuth-based quadruple therapy (Pylera®) in ...
ALVARO, Domenico +16 more
core +8 more sources
PLoS ONE, 2022 After performing liquid-liquid extraction with ethyl acetate and HCl, samples from 12 volunteers who performed sequential collections after taking a tablet of naproxen alone (n = 6) or associated with esomeprazole (n = 6) were analyzed in a triple ...
Gabriela Moraes Oliveira +6 more
doaj +2 more sources
The Korean Journal of Gastroenterology, 2020 Background/Aims: Non-cardiac chest pain (NCCP) is defined as recurrent angina pectoris-like pain without evidence of coronary heart disease, and is usually related to esophageal diseases, such as gastroesophageal reflux disease (GERD).
Jae Kyun Choi +6 more
doaj +1 more source